O	0	10	Comparison
O	11	13	of
B-Symptom	14	20	visual
I-Symptom	21	27	acuity
I-Symptom	28	32	loss
O	33	35	in
O	36	44	patients
O	45	49	with
O	50	59	different
O	60	66	stages
O	67	69	of
B-Disease	70	79	Stargardt
I-Disease	79	80	'
I-Disease	80	81	s
I-Disease	82	89	disease
O	89	90	.

O	92	94	To
O	95	106	investigate
O	107	108	a
O	109	119	previously
O	120	128	reported
O	129	140	observation
O	141	145	that
O	146	149	the
O	150	158	presence
O	159	161	of
O	162	169	diffuse
O	169	170	,
O	171	173	as
O	174	182	compared
O	183	187	with
O	188	197	localized
O	197	198	,
B-Symptom	199	205	fundus
I-Symptom	206	212	flecks
O	213	215	is
O	216	218	an
O	219	228	indicator
O	229	231	of
O	232	233	a
O	234	238	more
O	239	245	severe
O	246	252	course
O	253	256	for
B-Symptom	257	263	visual
I-Symptom	264	270	acuity
I-Symptom	271	272	(
I-Symptom	272	274	VA
I-Symptom	274	275	)
I-Symptom	276	280	loss
I-Symptom	281	287	beyond
I-Symptom	288	290	20
I-Symptom	290	291	/
I-Symptom	291	294	200
O	295	297	in
O	298	306	patients
O	307	311	with
B-Disease	312	321	Stargardt
I-Disease	321	322	'
I-Disease	322	323	s
I-Disease	324	331	disease
O	331	332	.

O	333	346	Retrospective
O	347	353	clinic
O	353	354	-
O	354	359	based
O	360	365	cross
O	365	366	-
O	366	375	sectional
O	376	381	study
O	381	382	.

O	383	387	Four
O	388	395	hundred
O	396	400	five
O	401	409	patients
O	410	414	with
B-Disease	415	424	Stargardt
I-Disease	424	425	'
I-Disease	425	426	s
I-Disease	427	434	disease
O	434	435	.

B-Characteristic	436	442	Visual
I-Characteristic	443	449	acuity
O	450	452	in
O	453	456	405
O	457	465	patients
O	466	470	with
B-Disease	471	480	Stargardt
I-Disease	480	481	'
I-Disease	481	482	s
I-Disease	483	490	disease
O	491	494	was
O	495	503	analyzed
O	504	506	at
O	507	512	their
O	513	520	initial
O	521	524	and
O	525	529	most
O	530	536	recent
O	537	543	visits
O	543	544	.

O	545	548	The
O	549	554	stage
O	555	557	of
B-Disease	558	567	Stargardt
I-Disease	567	568	'
I-Disease	568	569	s
I-Disease	570	577	disease
O	578	581	and
B-Characteristic	582	592	appearance
I-Characteristic	593	595	of
I-Characteristic	596	599	the
I-Characteristic	600	606	macula
O	607	611	were
O	612	620	recorded
O	620	621	.

O	622	625	The
O	626	635	diagnosis
O	636	639	and
O	640	645	stage
O	646	648	of
B-Disease	649	658	Stargardt
I-Disease	658	659	'
I-Disease	659	660	s
I-Disease	661	668	disease
O	669	673	were
O	674	679	based
O	680	682	on
O	683	686	the
O	687	693	extent
O	694	697	and
O	698	708	appearance
O	709	711	of
B-Symptom	712	718	fundus
I-Symptom	719	725	flecks
O	725	726	.

B-Characteristic	727	731	Best
I-Characteristic	731	732	-
I-Characteristic	732	741	corrected
I-Characteristic	742	744	VA
O	744	745	,
O	746	751	stage
O	752	754	of
B-Disease	755	764	Stargardt
I-Disease	764	765	'
I-Disease	765	766	s
I-Disease	767	774	disease
O	774	775	,
O	776	779	and
B-Characteristic	780	790	appearance
I-Characteristic	791	793	of
I-Characteristic	794	797	the
I-Characteristic	798	804	macula
O	805	807	at
O	808	811	the
O	812	819	initial
O	820	823	and
O	824	828	most
O	829	835	recent
O	836	842	visits
O	843	847	were
O	848	852	used
O	853	855	in
O	856	859	the
O	860	865	cross
O	865	866	-
O	866	875	sectional
O	876	884	analysis
O	884	885	.

O	886	888	At
O	889	894	their
O	895	902	initial
O	903	908	visit
O	908	909	,
O	910	913	199
O	914	922	patients
O	923	927	were
O	928	938	identified
O	939	941	as
O	942	948	having
B-Disease	949	954	stage
I-Disease	955	956	1
I-Disease	957	966	Stargardt
I-Disease	966	967	'
I-Disease	967	968	s
I-Disease	969	976	disease
O	976	977	,
O	978	980	of
O	981	985	whom
O	986	988	97
O	988	989	.
O	989	990	5
O	990	991	%
O	992	1002	maintained
B-Symptom	1003	1005	20
I-Symptom	1005	1006	/
I-Symptom	1006	1009	200
I-Symptom	1010	1012	or
I-Symptom	1013	1019	better
I-Symptom	1020	1022	VA
O	1023	1025	in
O	1026	1028	at
O	1029	1034	least
O	1035	1038	one
B-Anatomy	1039	1042	eye
O	1042	1043	.

O	1044	1047	One
O	1048	1055	hundred
O	1056	1062	eighty
O	1062	1063	-
O	1063	1067	five
O	1068	1072	were
O	1073	1083	identified
O	1084	1086	as
O	1087	1093	having
B-Disease	1094	1099	stage
I-Disease	1100	1101	2
I-Disease	1102	1104	or
I-Disease	1105	1110	stage
I-Disease	1111	1112	2
I-Disease	1112	1113	-
I-Disease	1113	1114	3
I-Disease	1115	1124	Stargardt
I-Disease	1124	1125	'
I-Disease	1125	1126	s
I-Disease	1127	1134	disease
O	1135	1143	combined
O	1143	1144	,
O	1145	1147	of
O	1148	1152	whom
O	1153	1155	83
O	1155	1156	.
O	1156	1157	2
O	1157	1158	%
O	1159	1169	maintained
B-Symptom	1170	1172	20
I-Symptom	1172	1173	/
I-Symptom	1173	1176	200
I-Symptom	1177	1179	VA
I-Symptom	1180	1182	or
I-Symptom	1183	1189	better
O	1189	1190	.

O	1191	1199	Patients
O	1200	1204	with
B-Disease	1205	1210	stage
I-Disease	1211	1212	1
O	1213	1217	were
O	1218	1222	more
O	1223	1229	likely
O	1230	1232	to
O	1233	1241	maintain
B-Symptom	1242	1244	20
I-Symptom	1244	1245	/
I-Symptom	1245	1248	200
I-Symptom	1249	1251	or
I-Symptom	1252	1258	better
I-Symptom	1259	1261	VA
O	1262	1264	in
O	1265	1267	at
O	1268	1273	least
O	1274	1277	one
B-Anatomy	1278	1281	eye
O	1282	1286	when
O	1287	1295	compared
O	1296	1300	with
O	1301	1309	patients
O	1310	1314	with
B-Disease	1315	1320	stage
I-Disease	1321	1322	2
I-Disease	1322	1323	/
I-Disease	1323	1328	stage
I-Disease	1329	1330	2
I-Disease	1330	1331	-
I-Disease	1331	1332	3
I-Disease	1333	1342	Stargardt
I-Disease	1342	1343	'
I-Disease	1343	1344	s
I-Disease	1345	1352	disease
O	1353	1354	(
O	1354	1358	chi2
O	1358	1359	(
O	1359	1360	1
O	1360	1361	)
O	1362	1363	=
O	1364	1366	21
O	1366	1367	.
O	1367	1369	25
O	1369	1370	,
O	1371	1372	P
O	1373	1374	<
O	1375	1376	0
O	1376	1377	.
O	1377	1380	001
O	1380	1381	)
O	1381	1382	.

O	1383	1389	Ninety
O	1389	1390	-
O	1390	1394	nine
O	1395	1402	percent
O	1403	1405	of
B-Disease	1406	1411	stage
I-Disease	1412	1413	1
O	1414	1422	patients
O	1423	1426	and
O	1427	1429	94
O	1429	1430	.
O	1430	1431	1
O	1431	1432	%
O	1433	1435	of
B-Disease	1436	1441	stage
I-Disease	1442	1443	2
I-Disease	1443	1444	/
I-Disease	1444	1449	stage
I-Disease	1450	1451	2
I-Disease	1451	1452	-
I-Disease	1452	1453	3
O	1454	1462	patients
O	1463	1473	maintained
B-Symptom	1474	1476	20
I-Symptom	1476	1477	/
I-Symptom	1477	1480	400
I-Symptom	1481	1483	or
I-Symptom	1484	1490	better
I-Symptom	1491	1493	VA
I-Symptom	1494	1496	in
I-Symptom	1497	1499	at
I-Symptom	1500	1505	least
I-Symptom	1506	1509	one
I-Symptom	1510	1513	eye
O	1514	1515	(
O	1515	1519	chi2
O	1519	1520	(
O	1520	1521	1
O	1521	1522	)
O	1523	1524	=
O	1525	1526	5
O	1526	1527	.
O	1527	1529	72
O	1529	1530	,
O	1531	1532	P
O	1533	1534	=
O	1535	1536	0
O	1536	1537	.
O	1537	1540	017
O	1540	1541	)
O	1541	1542	.

O	1543	1551	Patients
O	1552	1556	with
B-Disease	1557	1562	stage
I-Disease	1563	1564	1
I-Disease	1565	1574	Stargardt
I-Disease	1574	1575	'
I-Disease	1575	1576	s
I-Disease	1577	1584	disease
O	1585	1595	exhibiting
B-Symptom	1596	1602	fundus
I-Symptom	1603	1609	flecks
O	1610	1617	limited
O	1618	1620	to
O	1621	1624	the
B-Anatomy	1625	1634	posterior
I-Anatomy	1635	1639	pole
O	1640	1643	are
O	1644	1648	more
O	1649	1655	likely
O	1656	1658	to
O	1659	1667	maintain
O	1668	1669	a
O	1670	1675	level
O	1676	1678	of
B-Symptom	1679	1681	VA
I-Symptom	1682	1684	at
I-Symptom	1685	1687	20
I-Symptom	1687	1688	/
I-Symptom	1688	1691	200
I-Symptom	1692	1694	or
I-Symptom	1695	1701	better
O	1702	1706	when
O	1707	1715	compared
O	1716	1720	with
O	1721	1729	patients
O	1730	1734	with
B-Disease	1735	1740	stage
I-Disease	1741	1742	2
I-Disease	1742	1743	/
I-Disease	1743	1748	stage
I-Disease	1749	1750	2
I-Disease	1750	1751	-
I-Disease	1751	1752	3
I-Disease	1753	1760	disease
O	1761	1764	who
O	1765	1769	have
B-Symptom	1770	1777	diffuse
I-Symptom	1778	1784	fundus
I-Symptom	1785	1791	flecks
O	1791	1792	.

O	1793	1805	Nevertheless
O	1805	1806	,
O	1807	1811	over
O	1812	1814	80
O	1814	1815	%
O	1816	1818	of
O	1819	1822	the
O	1823	1831	patients
O	1832	1836	with
B-Disease	1837	1842	stage
I-Disease	1843	1844	2
I-Disease	1844	1845	/
I-Disease	1845	1850	stage
I-Disease	1851	1852	2
I-Disease	1852	1853	-
I-Disease	1853	1854	3
I-Disease	1855	1864	Stargardt
I-Disease	1864	1865	'
I-Disease	1865	1866	s
I-Disease	1867	1874	disease
O	1875	1880	still
O	1881	1891	maintained
B-Symptom	1892	1894	VA
I-Symptom	1895	1897	of
I-Symptom	1898	1900	20
I-Symptom	1900	1901	/
I-Symptom	1901	1904	200
I-Symptom	1905	1907	or
I-Symptom	1908	1914	better
O	1914	1915	.

O	1916	1920	Only
O	1921	1922	5
O	1922	1923	.
O	1923	1924	9
O	1924	1925	%
O	1926	1928	of
O	1929	1937	patients
O	1938	1942	with
B-Disease	1943	1948	stage
I-Disease	1949	1950	2
I-Disease	1950	1951	/
I-Disease	1951	1956	stage
I-Disease	1957	1958	2
I-Disease	1958	1959	-
I-Disease	1959	1960	3
O	1961	1964	had
B-Symptom	1965	1967	VA
I-Symptom	1968	1974	levels
I-Symptom	1975	1980	worse
I-Symptom	1981	1985	than
I-Symptom	1986	1988	20
I-Symptom	1988	1989	/
I-Symptom	1989	1992	400
O	1992	1993	.

O	1994	1996	In
O	1997	2000	our
O	2001	2007	cohort
O	2008	2010	of
O	2011	2019	patients
O	2020	2024	with
B-Disease	2025	2034	Stargardt
I-Disease	2034	2035	'
I-Disease	2035	2036	s
I-Disease	2037	2044	disease
O	2045	2048	and
B-Symptom	2049	2056	diffuse
I-Symptom	2057	2063	fundus
I-Symptom	2064	2070	flecks
O	2070	2071	,
O	2072	2075	the
O	2076	2084	majority
O	2085	2087	of
O	2088	2096	patients
O	2097	2100	did
O	2101	2104	not
B-Symptom	2105	2109	lose
I-Symptom	2110	2112	VA
O	2113	2115	to
O	2116	2117	a
O	2118	2125	greater
O	2126	2132	extent
O	2133	2137	than
O	2138	2143	those
O	2144	2148	with
B-Symptom	2149	2158	localized
I-Symptom	2159	2165	flecks
O	2165	2166	.
